Genetic diversity, antimicrobial resistance and extended-spectrum β-lactamase type of Escherichia coli isolates from chicken, dog, pig and yak in Gansu and Qinghai Provinces, China

Yining Wang,Jianhua Zhou,Xuerui Li,Lina Ma,Xiaoan Cao,Wen Hu,Lu Zhao,Wenxian Jing,Xi Lan,Youquan Li,Xiaowei Gong,Qiwei Chen,Laszlo Stipkvits,Susan Szathmary,Kazimierz Tarasiuk,Zygmunt Pejsak,Yongsheng Liu
DOI: https://doi.org/10.1016/j.jgar.2020.06.028
IF: 4.349
2020-09-01
Journal of Global Antimicrobial Resistance
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>We investigated the genetic diversity, phylogenetic grouping, antimicrobial resistance, and extended-spectrum β-lactamase (ESBL) type of <em>Escherichia coli</em> isolates from chickens, dogs, pigs, and yaks in six prefectures of Gansu and Qinghai Provinces in China.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p><em>E. coli</em> was isolated from diarrheic and healthy fecal samplings. Multilocus sequence typing (MLST), phylogenetic grouping, antimicrobial resistance, and ESBL profiles were all investigated.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>142 total MLST sequence types were identified from 400 <em>E. coli</em> isolates. eBURST clustering analysis assorted the 142 into 19 clonal complexes and 67 singletons. PCR phylogenetic typing identified the isolation rate of potentially pathogenic B2/D group isolates versus all <em>E. coli</em> from healthy animal samples to be 12.5%, and from diarrheic samples to be 17.5%. Our antimicrobial susceptibility test revealed 78 drug resistance patterns. <em>E. coli</em> drug resistance rates were highest to doxycycline, ampicillin, and tetracycline; polymyxin and meropenem had the lowest rates. All polymyxin resistant <em>E. coli</em> isolates are <em>mcr-1</em> gene positive. A total of 62 ESBL isolates were identified. ESBL prevalence in diarrheic samplings was 55%, and in healthy animals 5.6%. TEM (96.8%) is the predominant ESBL type, followed by CTM (44%), and SHV (19%).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p><em>E. coli</em> isolates in the study area have a high diversity of genetics and drug resistance patterns, but relatively low isolation rates of potentially pathogenic groups. However, somewhat high isolation rates of multiple drug resistant <em>E. coli</em>, particularly ESBL <em>E. coli</em> isolates, require continual surveillance of <em>E. coli</em> prevalence in animals within these areas.</p>
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?